Fischer Medical Ventures Limited (FISCHER) — Board Meeting
Fischer Medical Ventures reported audited consolidated results for the year ended March 31, 2026, showing total assets of ₹67,101.06 lakhs and net profit attributable to owners of ₹(586.66) lakhs, with basic EPS at ₹(0.11). The board recommended a final dividend of ₹0.05 per share and approved a 10:1 equity share split effective September 12, 2025. The statutory auditor issued an unmodified opinion, confirming compliance with SEBI LODR and Ind AS, while noting no material impact from new labour codes or subsidiary transfers. Internal auditor S. Ramanand Aiyer & Co was re-appointed for FY 2026-27.
About Fischer Medical Ventures Limited (FISCHER)
Healthcare · Healthcare Equipment & Supplies · Listed on NSE
📡 Get AI alerts when FISCHER files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track FISCHER — Free💡 Ask AI about this filing
📊 More FISCHER filings
- Financial Results — 29 June 2026 Fischer Medical Ventures Limited announced that its trading window for equity shares will close on J...
- share transfer — 9 April 2026 Fischer Medical Ventures Limited received a share transfer agent certificate confirming dematerializ...
- regulation 31 — 8 April 2026 Shankar Varadharajan, promoter of Fischer Medical Ventures Limited, declared under SEBI Regulation 3...
- 🟡 Board Meeting — 31 March 2026 The board approved the conversion of 60 lakh warrants into equity shares at ₹23.40 per share, receiv...
- Announcement — 30 March 2026 Fischer Medical Ventures Limited filed a general corporate document on the NSE. Without access to th...
🔥 Also filed on 31 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when FISCHER files new disclosures
Track FISCHER filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track FISCHER — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research